APO RESEARCH · REPORT
Left Ventricular Assist Device (LVAD)
A left ventricular assist device (LVAD) is a pump that we use for patients who have reached end-stage heart failure.
Product & engineering
Understand the product.
A left ventricular assist device (LVAD) is a pump that we use for patients who have reached end-stage heart failure.
Selected research
Market Outlook & Growth Opportunities
Global Left Ventricular Assist Device (LVAD) Market Outlook and Growth Opportunities 2026
Market perspective
A left ventricular assist device (LVAD) is a pump that we use for patients who have reached end-stage heart failure.
AbioMed, Abbott (Thoratec), Medtronic (HeartWare), Berlin Heart, etc. are the leaders of the industry, with high-end customers.
This report provides an overview of the global Left Ventricular Assist Device (LVAD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Left Ventricular Assist Device (LVAD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Left Ventricular Assist Device (LVAD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Left Ventricular Assist Device (LVAD) market size, projected growth trends, production technologies, key applications, and end-use industries.
Left Ventricular Assist Device (LVAD) Segment by Company
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
ReliantHeart
Market Segment by Product Type
BTT Therapy
Destination Therapy (DT)
Left Ventricular Assist Device (LVAD) Segment by Type
BTT Therapy
Destination Therapy (DT)
Other
Left Ventricular Assist Device (LVAD) Segment by Application
Hospitals
Clinics
Left Ventricular Assist Device (LVAD) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Left Ventricular Assist Device (LVAD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Left Ventricular Assist Device (LVAD) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Left Ventricular Assist Device (LVAD) significant trends, drivers, influence factors in global and regions.
6. To analyze Left Ventricular Assist Device (LVAD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Left Ventricular Assist Device (LVAD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Left Ventricular Assist Device (LVAD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Left Ventricular Assist Device (LVAD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Left Ventricular Assist Device (LVAD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Left Ventricular Assist Device (LVAD) industry.
Chapter 3: Detailed analysis of Left Ventricular Assist Device (LVAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Left Ventricular Assist Device (LVAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Left Ventricular Assist Device (LVAD) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- BTT Therapy
- Destination Therapy (DT)
- Other
Applications
- Hospitals
- Clinics
Companies covered
- AbioMed
- Abbott (Thoratec)
- Medtronic (HeartWare)
- Berlin Heart
- Jarvik Heart
- Sun Medical Technology Research
- ReliantHeart
- Market Segment by Product Type
- BTT Therapy
- Destination Therapy (DT)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value (2021-2032)
- 1.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume (2021-2032)
- 1.2.3 Global Left Ventricular Assist Device (LVAD) Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Left Ventricular Assist Device (LVAD) Market Dynamics
- 2.1 Left Ventricular Assist Device (LVAD) Industry Trends
- 2.2 Left Ventricular Assist Device (LVAD) Industry Drivers
- 2.3 Left Ventricular Assist Device (LVAD) Industry Opportunities and Challenges
- 2.4 Left Ventricular Assist Device (LVAD) Industry Restraints
3 Left Ventricular Assist Device (LVAD) Market by Company
- 3.1 Global Left Ventricular Assist Device (LVAD) Company Revenue Ranking in 2025
- 3.2 Global Left Ventricular Assist Device (LVAD) Revenue by Company (2021-2026)
- 3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Company (2021-2026)
- 3.4 Global Left Ventricular Assist Device (LVAD) Average Price by Company (2021-2026)
- 3.5 Global Left Ventricular Assist Device (LVAD) Company Ranking (2024-2026)
- 3.6 Global Left Ventricular Assist Device (LVAD) Company Manufacturing Base and Headquarters
- 3.7 Global Left Ventricular Assist Device (LVAD) Company Product Type and Application
- 3.8 Global Left Ventricular Assist Device (LVAD) Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Left Ventricular Assist Device (LVAD) Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Left Ventricular Assist Device (LVAD) Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Left Ventricular Assist Device (LVAD) Market by Type
- 4.1 Left Ventricular Assist Device (LVAD) Type Introduction
- 4.1.1 BTT Therapy
- 4.1.2 Destination Therapy (DT)
- 4.1.3 Other
- 4.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type
- 4.2.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2021-2032)
- 4.2.3 Global Left Ventricular Assist Device (LVAD) Sales Volume Share by Type (2021-2032)
- 4.3 Global Left Ventricular Assist Device (LVAD) Sales Value by Type
- 4.3.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2021-2032)
- 4.3.3 Global Left Ventricular Assist Device (LVAD) Sales Value Share by Type (2021-2032)
5 Left Ventricular Assist Device (LVAD) Market by Application
- 5.1 Left Ventricular Assist Device (LVAD) Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application
- 5.2.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2021-2032)
- 5.2.3 Global Left Ventricular Assist Device (LVAD) Sales Volume Share by Application (2021-2032)
- 5.3 Global Left Ventricular Assist Device (LVAD) Sales Value by Application
- 5.3.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2021-2032)
- 5.3.3 Global Left Ventricular Assist Device (LVAD) Sales Value Share by Application (2021-2032)
6 Left Ventricular Assist Device (LVAD) Regional Sales and Value Analysis
- 6.1 Global Left Ventricular Assist Device (LVAD) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Left Ventricular Assist Device (LVAD) Sales by Region (2021-2032)
- 6.2.1 Global Left Ventricular Assist Device (LVAD) Sales by Region: 2021-2026
- 6.2.2 Global Left Ventricular Assist Device (LVAD) Sales by Region (2027-2032)
- 6.3 Global Left Ventricular Assist Device (LVAD) Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2021-2032)
- 6.4.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region: 2021-2026
- 6.4.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2027-2032)
- 6.5 Global Left Ventricular Assist Device (LVAD) Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Left Ventricular Assist Device (LVAD) Sales Value (2021-2032)
- 6.6.2 North America Left Ventricular Assist Device (LVAD) Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Left Ventricular Assist Device (LVAD) Sales Value (2021-2032)
- 6.7.2 Europe Left Ventricular Assist Device (LVAD) Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Left Ventricular Assist Device (LVAD) Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Left Ventricular Assist Device (LVAD) Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Left Ventricular Assist Device (LVAD) Sales Value (2021-2032)
- 6.9.2 South America Left Ventricular Assist Device (LVAD) Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value Share by Country, 2025 VS 2032
7 Left Ventricular Assist Device (LVAD) Country-level Sales and Value Analysis
- 7.1 Global Left Ventricular Assist Device (LVAD) Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Left Ventricular Assist Device (LVAD) Sales by Country (2021-2032)
- 7.3.1 Global Left Ventricular Assist Device (LVAD) Sales by Country (2021-2026)
- 7.3.2 Global Left Ventricular Assist Device (LVAD) Sales by Country (2027-2032)
- 7.4 Global Left Ventricular Assist Device (LVAD) Sales Value by Country (2021-2032)
- 7.4.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Country (2021-2026)
- 7.4.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.9.2 France Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.16.2 China Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.19.2 India Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Left Ventricular Assist Device (LVAD) Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Left Ventricular Assist Device (LVAD) Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Left Ventricular Assist Device (LVAD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 AbioMed
- 8.1.1 AbioMed Company Information
- 8.1.2 AbioMed Business Overview
- 8.1.3 AbioMed Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.1.4 AbioMed Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.1.5 AbioMed Recent Developments
- 8.2 Abbott (Thoratec)
- 8.2.1 Abbott (Thoratec) Company Information
- 8.2.2 Abbott (Thoratec) Business Overview
- 8.2.3 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.2.5 Abbott (Thoratec) Recent Developments
- 8.3 Medtronic (HeartWare)
- 8.3.1 Medtronic (HeartWare) Company Information
- 8.3.2 Medtronic (HeartWare) Business Overview
- 8.3.3 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.3.5 Medtronic (HeartWare) Recent Developments
- 8.4 Berlin Heart
- 8.4.1 Berlin Heart Company Information
- 8.4.2 Berlin Heart Business Overview
- 8.4.3 Berlin Heart Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Berlin Heart Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.4.5 Berlin Heart Recent Developments
- 8.5 Jarvik Heart
- 8.5.1 Jarvik Heart Company Information
- 8.5.2 Jarvik Heart Business Overview
- 8.5.3 Jarvik Heart Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Jarvik Heart Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.5.5 Jarvik Heart Recent Developments
- 8.6 Sun Medical Technology Research
- 8.6.1 Sun Medical Technology Research Company Information
- 8.6.2 Sun Medical Technology Research Business Overview
- 8.6.3 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.6.5 Sun Medical Technology Research Recent Developments
- 8.7 ReliantHeart
- 8.7.1 ReliantHeart Company Information
- 8.7.2 ReliantHeart Business Overview
- 8.7.3 ReliantHeart Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.7.4 ReliantHeart Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.7.5 ReliantHeart Recent Developments
- 8.8 Market Segment by Product Type
- 8.8.1 Market Segment by Product Type Company Information
- 8.8.2 Market Segment by Product Type Business Overview
- 8.8.3 Market Segment by Product Type Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Market Segment by Product Type Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.8.5 Market Segment by Product Type Recent Developments
- 8.9 BTT Therapy
- 8.9.1 BTT Therapy Company Information
- 8.9.2 BTT Therapy Business Overview
- 8.9.3 BTT Therapy Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.9.4 BTT Therapy Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.9.5 BTT Therapy Recent Developments
- 8.10 Destination Therapy (DT)
- 8.10.1 Destination Therapy (DT) Company Information
- 8.10.2 Destination Therapy (DT) Business Overview
- 8.10.3 Destination Therapy (DT) Left Ventricular Assist Device (LVAD) Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Destination Therapy (DT) Left Ventricular Assist Device (LVAD) Product Portfolio
- 8.10.5 Destination Therapy (DT) Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Left Ventricular Assist Device (LVAD) Value Chain Analysis
- 9.1.1 Left Ventricular Assist Device (LVAD) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Left Ventricular Assist Device (LVAD) Sales Mode & Process
- 9.2 Left Ventricular Assist Device (LVAD) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Left Ventricular Assist Device (LVAD) Distributors
- 9.2.3 Left Ventricular Assist Device (LVAD) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst